LEADER 01585nam  2200457   450 
001 9910717375203321
005 20221105100850.0
035   $a(CKB)4100000012064014
035   $a(NjHacI)994100000012064014
035   $a(OCoLC)1237044285
035   $a(EXLCZ)994100000012064014
100   $a20221105d2020      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aEnd-stage renal disease and depression $ea systematic review /$fKarli Kondo [and four others]
210  1$aWashington, DC :$cDepartment of Veterans Affairs (US),$d[2020]
210  4$dİ2020
215   $a1 online resource (vi, 101 pages) $cillustrations
225 1 $aEvidence-based synthesis program
300   $a"January 2020."
320   $aIncludes bibliographical references.
410  0$aEvidence-based synthesis program (Series)
517   $aEnd-stage renal disease and depression 
606   $aChronic renal failure
606   $aDepression, Mental$xDiagnosis
606   $aDepression, Mental$xTreatment
615  0$aChronic renal failure.
615  0$aDepression, Mental$xDiagnosis.
615  0$aDepression, Mental$xTreatment.
676   $a616.6
700   $aKondo$b Karli$01353458
712 02$aUnited States.$bDepartment of Veterans Affairs.$bHealth Services Research and Development Service,
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910717375203321
996   $aEnd-stage renal disease and depression$93254456
997   $aUNINA